About Pipeline Biotech

   

From chemistry to clinical phase one

Pipeline Biotech is a pharmacological contract research organisation with the capacity to combine advanced molecular biology with pre-clinical research. Our primary objective is to feed pharmacological companies with knowledge acquired from focused research studies aimed at drug discovery and early drug development. As we possess the know-how, the competencies, the laboratory facilities and the experience needed to design and carry out special research programmes, we are able to conduct research and carry out most of the laboratory animal experiments required to identify and prove the concept of new lead candidates.

Dedication to clients

We at Pipeline Biotech are dedicated to fulfilling the needs of our clients. We are adept at carrying out experimental, analytical and preparative assignments. The tasks we perform may be part of an extensive research programme, they may require mass routine screenings, or they may constitute single cases in their own right. No two assignments are exactly the same – nor can they be studied the same way.

… requires customer specific research

Therefore, unlike most research companies we do more than “simply” supply standard services – we design our research programmes to meet our customers’ needs exactly, tailoring them to match the specific research or development project in question precisely.

Laboratory expertise

Our laboratories are designed and approved for experimental animal research, cell biology and molecular biology. Lab animals can be housed at different levels of barrier protection: from germ-free isolator units and laminar flow units to SPF barrier units. Naturally, only tested and approved procedures are used, and all animal studies are performed by highly trained staff under veterinary supervision. We always maintain full control of our techniques and the environmental factors that relate to the quality of the animals, their care and the experiments for which they are used.

Quality assurance and GLP

Studies must comply with the principles of Good Laboratory Practice (GLP) in order to reach the official “quality” level. Few clients need GLP in the earliest phases of drug discovery, but for those who do, we have implemented a quality assurance programme that follows the OECD principles of GLP. Pipeline Biotech has been GLP compliant since 2003. Our clients are international pharmaceutical and biotechnological companies and the studies are Pharmacokinetic and toxicological.

   

Technologies related to genomics have already generated a boom in the volume of information available about genes and proteins. As a natural result of this development, the number of anti-cancer drugs currently undergoing clinical development has increased dramatically.